Financhill
Back

Haemonetics 10K Form

Sell
50

HAE
Haemonetics

Last Price:
$62.97
Seasonality Move:
0.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive HAE News And Ratings

See the #1 stock for the next 7 days that we like better than HAE

HAE Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $35.2M
Price / Cash Flow: 45.61
Annual Sales: $18.05
Price / Book: 3.49

Profitability

EPS (TTM): 2.54000
Net Income (TTM): $130.1M
Gross Margin: $691.5M
Return on Equity: 14.16%
Return on Assets: 5.42%

Haemonetics Earnings Forecast

Key Haemonetics Financial Ratios

  • The Gross Profit Margin over the past 33 years for HAE is 52.83%.
  • The Selling, General & Administrative Expenses for HAE have been equal to 32.98% of Gross Profit Margin.
  • The Research & Development expenses have been 4.16% of Revenue.
  • The Interest Expense is 11.07% of Operating Income.
  • The Net Earning history of HAE is 8.98% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Haemonetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: HAE
CUSIP: 405024
Website: haemonetics.com

Debt

Debt-to-Equity Ratio: 1.35
Current Ratio: 3.97
Quick Ratio: 2.1

Price-to-Earnings

Trailing P/E Ratio: 27.52
Forward P/E Ratio: 12.63

HAE Technical Analysis vs Fundamental Analysis

Sell
50
Haemonetics (HAE) is a Sell

Is Haemonetics a Buy or a Sell?

  • Haemonetics stock is rated a Sell
    The current Haemonetics [HAE] share price is $63.02. The Score for HAE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.